COVID-19 caused many interruptions in clinical trials. After a brief pause in external clinical research, clinical studies involving use of the FDA-cleared ID-Cap System from etectRx resumed in July of 2020. etectRx sought to understand if patients were engaged with our digital pill system when used to track and report their medication-taking in a clinical study conducted during the COVID-19 pandemic.
